Marijuana Stock Cronos Group Slips After Analyst Trims Target Price

Cowen & Co.’s Vivien Azer reiterated a Market Perform rating on Cronos and lowered her price target by $3 Canadian dollars, to C$26. She writes that the company’s results were “marred by supply constraints that fell short of demand.”